The right question isn't "GLP-1 or statin." It's recognizing that we may now have two largely independent levers on cardiovascular risk, and the evidence supports using both, not choosing between them
The warning label reports an increase in diabetic retinopathy complications for diabetic patients taking the drug
Uranyl formate was from Bioscientific
Eli Lilly, which made more than $5 billion from its Mounjaro and Zepbound products in the fourth quarter of 2024, said anyone selling mass compounded tirzepatide, including by referring to it as personalized, tailored or something similar, is breaking the law and deceiving patients. We will continue to take action to stop these illegal actors and urgently call on regulators and law enforcement to do the same, the company said
17,19,22,26 Given incomplete and inconsistent reporting, AE findings were summarized descriptively